Global Health Research center

Tampa, Florida 33615

0 studies enrolling now · 2 studies all time

What they study most

Influenza, Human

Studies at this site

• Safety and Immunogenicity of Different Formulations of an MF59-Adjuvanted Influenza Vaccine in Older Adults ≥50 Years of Age — Completed
• The Celljuvant Study: A Phase 3 Immunogenicity and Safety Study of aQIVc Vaccine in Adults Aged 50 Years and Older — Completed